Trial · NCT07910994
A Prospective Study of Cognitive Changes in Retired and Late-Career Professional Soccer Players
NCT07910994, Not yet recruiting, University Hospital, Strasbourg, France
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Prospective Study of Cognitive Changes in Retired and Late-Career Professional Soccer Players. Trials, record NCT07910994. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910994
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Prospective Study of Cognitive Changes in Retired and Late-Career Professional Soccer Players
- NCT number
- NCT07910994
- Status
- Not yet recruiting
- Enrollment
- 75 participants, estimated
- Lead sponsor
- University Hospital, Strasbourg, France
- Conditions
- Cognitive Impairment, Chronic Traumatic Encephalopathy (CTE)
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Attention and Concentration Assessed by the Computerized d2-R Test | baseline | Attention and concentration will be assessed using the computerized d2-R test administered remotely. Performance will be evaluated using standardized test scores according to the test manual. |
| Primary | Executive Functioning Assessed by the BRIEF-A Self-Report Questionnaire | baseline | Executive functioning and difficulties in everyday executive functioning will be assessed using the self-report version of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A). Raw scores for the clinical scales and composite indices will be converted into standardized T-scores according to the test manual. Higher T-scores indicate greater executive-function difficulties. |
| Primary | Executive Functioning Assessed by the BRIEF-A Informant-Report Questionnaire | baseline | Executive functioning and difficulties in everyday executive functioning will be assessed using the informant-report version of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A). Raw scores for the clinical scales and composite indices will be converted into standardized T-scores according to the test manual. Higher T-scores indicate greater executive-function difficulties. |
| Primary | Subjective Memory Complaints Assessed by the McNair and Kahn Questionnaire | baseline | Subjective memory complaints will be assessed using the McNair and Kahn Memory Complaint Questionnaire. The total score ranges from 0 to 45, with higher scores indicating more severe subjective memory complaints. |
| Primary | Emotion Regulation Difficulties Assessed by the Difficulties in Emotion Regulation Scale-16 (DERS-16) | baseline | Difficulties in emotion regulation will be assessed using the 16-item Difficulties in Emotion Regulation Scale (DERS-16). The total score ranges from 16 to 80, with higher scores indicating greater difficulties in emotion regulation. |
| Primary | Anxiety Symptoms Assessed by the Generalized Anxiety Disorder-7 (GAD-7) | baseline | Anxiety symptoms will be assessed using the Generalized Anxiety Disorder-7 (GAD-7), a 7-item patient-reported questionnaire. The total score ranges from 0 to 21, with higher scores indicating greater anxiety symptom severity. |
| Primary | Depressive Symptoms Assessed by the Patient Health Questionnaire-9 (PHQ-9) | baseline | Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported questionnaire. The total score ranges from 0 to 27, with higher scores indicating greater depressive symptom severity. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910994
GET https://conductscience.org/api/trials/v1/NCT07910994/registered